← FDA DRUG APPROVALS

FDA ANDA · ANDA200908

LABETALOL HYDROCHLORIDE

Sponsor: PH HEALTH

APPLICATION
ANDA200908
TYPE
ANDA
ORIGINAL APPROVAL
2012-07-10
LATEST ACTION
2012-07-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

LABETALOL HYDROCHLORIDEDiscontinued
LABETALOL HYDROCHLORIDE 300MG · TABLET · ORAL
LABETALOL HYDROCHLORIDEDiscontinued
LABETALOL HYDROCHLORIDE 100MG · TABLET · ORAL
LABETALOL HYDROCHLORIDEDiscontinued
LABETALOL HYDROCHLORIDE 200MG · TABLET · ORAL

Approval history

2012-07-10Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →